当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 现金流量表

万泰生物

(603392)

  

流通市值:315.72亿  总市值:315.72亿
流通股本:12.64亿   总股本:12.64亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,093,038,877.15428,230,392.312,438,221,560.561,803,955,458.74
  收到的税费返还--1,489,586.8117,053.73
  收到其他与经营活动有关的现金93,595,267.9148,814,241.98139,241,305.72117,080,445.68
  经营活动现金流入小计1,186,634,145.06477,044,634.292,578,952,453.091,921,052,958.15
  购买商品、接受劳务支付的现金293,359,008.61144,578,081.77643,215,533.89419,100,138.2
  支付给职工以及为职工支付的现金585,146,072.15352,833,940.71,034,628,104.58798,829,410.92
  支付的各项税费103,313,371.3659,140,142.78164,693,486.34107,439,584.92
  支付其他与经营活动有关的现金286,140,326.62152,536,705.67646,661,285.18588,399,269.44
  经营活动现金流出小计1,267,958,778.74709,088,870.922,489,198,409.991,913,768,403.48
  经营活动产生的现金流量净额-81,324,633.68-232,044,236.6389,754,043.17,284,554.67
二、投资活动产生的现金流量:
  收回投资收到的现金5,068,135,631.643,526,131,777.474,647,311,628.273,984,425,204.45
  取得投资收益收到的现金106,743,737.3997,123,533.24114,450,861.91102,983,184.43
  处置固定资产、无形资产和其他长期资产收回的现金净额3,5211,623210,726,017.0548,990.85
  收到的其他与投资活动有关的现金--5,775,292.24302,022.04
  投资活动现金流入小计5,174,882,890.033,623,256,933.714,978,263,799.474,087,759,401.77
  购建固定资产、无形资产和其他长期资产支付的现金214,356,455.96100,204,503.7805,164,493.44557,471,858.41
  投资支付的现金--4,929,122,930.22923,443.68
  支付其他与投资活动有关的现金4,699,504,427.93,207,504,427.92,985,107.83,606,361,200
  投资活动现金流出小计4,913,860,883.863,307,708,931.65,737,272,531.464,164,756,502.09
  投资活动产生的现金流量净额261,022,006.17315,548,002.11-759,008,731.99-76,997,100.32
三、筹资活动产生的现金流量:
  取得借款收到的现金136,036,105.7967,370,265.08343,558,490.81249,073,800.99
  收到其他与筹资活动有关的现金--299.26-2,851,954.56
  筹资活动现金流入小计136,036,105.7967,369,965.82343,558,490.81251,925,755.55
  偿还债务支付的现金183,196,291.1258,454,271.17319,007,771.34231,825,639.41
  分配股利、利润或偿付利息支付的现金1,192,170.82222,620.032,277,526.661,314,939.15
  支付其他与筹资活动有关的现金1,969,335.71,434,098.221,801,532.27,601,461.63
  筹资活动现金流出小计186,357,797.6460,110,989.4343,086,830.2240,742,040.19
  筹资活动产生的现金流量净额-50,321,691.857,258,976.42471,660.6111,183,715.36
四、汇率变动对现金及现金等价物的影响-25,684,302.87-12,590,723.87-13,270,093.55-4,670,237.65
五、现金及现金等价物净增加额103,691,377.7778,172,018.03-682,053,121.83-63,199,067.94
  加:期初现金及现金等价物余额1,344,952,704.671,344,952,704.672,027,005,826.52,027,005,826.5
  期末现金及现金等价物余额1,448,644,082.441,423,124,722.71,344,952,704.671,963,806,758.56
补充资料:
  净利润-132,375,087.05--413,963,529.44-
  资产减值准备27,956,086.18-207,361,022.12-
  固定资产和投资性房地产折旧151,364,655.65-262,816,779.48-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧151,364,655.65-262,816,779.48-
  无形资产摊销35,115,634.51-53,278,499.24-
  长期待摊费用摊销10,279,255.26-21,725,256.4-
  处置固定资产、无形资产和其他长期资产的损失1,418,439.81--60,231,327.31-
  固定资产报废损失496,582.69-2,193,208.09-
  公允价值变动损失-10,324,525.44--48,297,071.98-
  财务费用23,237,872.04-14,660,009.6-
  投资损失-32,602,360.45--66,215,195.97-
  递延所得税-23,394,799--94,845,344.69-
  其中:递延所得税资产减少-23,394,799--94,845,344.69-
  存货的减少-98,893,210.5--40,540,197.18-
  经营性应收项目的减少6,818,431.99-398,160,460.04-
  经营性应付项目的增加-88,104,806.38--183,403,743.15-
  其他-3,555,225.52--14,145,472.91-
  不涉及现金收支的投资和筹资活动金额其他项目34,825,432.52-8,341,962.59-
  现金的期末余额1,448,644,082.44-1,344,952,704.67-
  减:现金的期初余额1,344,952,704.67-2,027,005,826.5-
  现金及现金等价物的净增加额103,691,377.77--682,053,121.83-
公告日期2026-08-202026-04-282026-04-212025-10-30
审计意见(境内)标准无保留意见
TOP↑